Abstract PR010: Potentiating the efficacy of immune checkpoint blockade by targeting the epithelial-to-mesenchymal transition (EMT) in breast carcinomas
Anushka Dongre(Whitehead Institute for Biomedical Research), Robert A. Weinberg(Whitehead Institute for Biomedical Research), Anna Martner(University of Gothenburg), Ferenc Reinhardt(Whitehead Institute for Biomedical Research), Maria Zagorulya(The Francis Crick Institute), Tuba Banaz(Whitehead Institute for Biomedical Research), Mohammad Rashidian(Harvard University), Sunita Nepal(Whitehead Institute for Biomedical Research), Prat Thiru(Whitehead Institute for Biomedical Research), Elinor Ng Eaton(Whitehead Institute for Biomedical Research), Stefani Spranger(University of Chicago)
Cited by 0
Related Papers
The basics of epithelial-mesenchymal transition
|Journal of Clinical Investigation|2009|10.1k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k